Alyeska Investment Group, L.P. Profound Medical Corp. Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Profound Medical Corp. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 160,000 shares of PROF stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,000Holding current value
$1 Million% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding PROF
# of Institutions
55Shares Held
13.5MCall Options Held
1.2KPut Options Held
5K-
Fil LTD Hamilton, D01.8MShares$11.3 Million0.01% of portfolio
-
Gagnon Securities LLC1.65MShares$10.4 Million2.68% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.21MShares$7.61 Million0.18% of portfolio
-
Timelo Investment Management Inc.912KShares$5.73 Million4.82% of portfolio
-
Gagnon Advisors, LLC897KShares$5.63 Million4.87% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $131M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...